• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Immune Responses in humanized Mice with Xenogeneic Chimerism

Immune Responses in humanized Mice with Xenogeneic Chimerism

Markus A. Hölzl (ORCID: )
  • Grant DOI 10.55776/J3416
  • Funding program Erwin Schrödinger
  • Status ended
  • Start June 1, 2013
  • End March 31, 2016
  • Funding amount € 145,130

Disciplines

Biology (10%); Clinical Medicine (30%); Medical-Theoretical Sciences, Pharmacy (60%)

Keywords

    Xenotransplantation, Tolerance Induction, Mixed Xenogeneic Chimerism, Central Tolerance, Humanized Mouse Model, T-cell cell tolerance

Abstract Final report

Organ transplantation is the only curative procedure with the potential to restore normal life quality in patients with end-stage organ-failure. The number of available donor organs, however, limits its applicability. Xenotransplantation poses a solution for this problem, since it allows the generation of organs "on demand". Despite recent advances, the use of the procedure is limited due to strong rejection-reactions mediated by antibodies, T-cells and NK-cells. Problematically, these rejection-reactions are too strong to be controlled by conventional immunosuppression. Immune tolerance is therefore likely needed for the success of clinical xenotransplantation. Studies in rodents have shown that mixed chimerism can promote tolerance of T-cells, B-cells and NK-cells. The host laboratory has adapted the study into a human/porcine setting and generated a humanized mouse model demonstrating that mixed xenogeneic chimerism can induce tolerance of human T-cells. By employing the humanized mouse model we will investigate the impact of porcine mixed xenochimerism on T- cell functionality, on the induction of T-cell tolerance and on a possible carryover of porcine pathogens to human cells within humanized mice. The proposed experiments will deliver valuable information about xenochimerism and its potential and feasibility to induce tolerance. Since a potential carryover of porcine pathogens to the human recipient cannot be excluded, the presented study will also have profound impact on the conception of future studies. Overall, we anticipate that the project will contribute to move the xenogeneic organ transplantation towards a clinical applicability.

Humanized mice are mice are animals which harbor a human immune system. The human immune system can grow and develop in those mice which makes it possible to monitor, investigate and even manipulate this immune system At Columbia University medical center I wanted to use the humanized mouse to investigate if it is possible to transplant pig organs into an organism with a human immune system. Furthermore, we wanted to see if the human immune cells can protect the pig cells from pathogens that would otherwise threaten to destroy the pig organs. For obvious reasons, this procedure cannot be done directly with humans because it would cause life-threatening immune reactions. However, the same procedure is possible when humanized mice are used as proxy organism. During the course of my research stay at Columbia University Medical Center, I generated numerous humanized mice and furthermore transplanted pig cells into those mice. The human immune system, was accepting the pig cells without rejecting them. However, and this was startling us, the human immune system could not recognize pig cells and human control cells at all. The reason for this was a failure in the humanized mouse system to mount a successful vaccination response. In order to find out, why vaccination did not work, we started to set up several experiments. These experiments addressed several facets of the humanized mouse, namely the mouse thymus and the mouse lymph nodes. By our experiments, we found out that the mouse thymus was causing problems and allowed the development of human cells in it. We therefore concluded that its presence is disturbing and decided that it is best to remove it. Indeed, we could confirm that the removal of the mouse thymus solved to problem. We furthermore found out, that the mouse lymph nodes were underdeveloped and not normal. Since lymph nodes are important for successful vaccination responses, we concluded that humanized mice have problems to build functioning lymph nodes and we decided to develop methods to repair the mouse lymph nodes. These methods involved the injection of human immune cells into newborn mice, because we assumed that the presence of immune cells at birth is necessary to develop good lymph nodes. We found out that newborn mice which received human cells indeed developed bigger lymph nodes and better lymph node structure. However, many of those mice started to show severe signs of autoimmunity. Concluding in brief, the humanized mouse model, in theory, is an attractive tool which would allow the investigation and manipulation of an in vivo immune system. Practically, however, the model has to be optimized so that certain flaws, like the inability to induce a vaccination response and the spontaneous occurrence of autoimmune reactions, can be overcome.

Research institution(s)
  • Columbia University Medical Center - 100%
  • St. Anna Kinderkrebsforschung GmbH - 100%

Research Output

  • 38 Citations
  • 1 Publications
Publications
  • 2014
    Title Xenograft Tolerance and Immune Function of Human T Cells Developing in Pig Thymus Xenografts
    DOI 10.4049/jimmunol.1302886
    Type Journal Article
    Author Kalscheuer H
    Journal The Journal of Immunology
    Pages 3442-3450
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF